Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mapp Biopharmaceutical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Mapp Biopharmaceutical

Mapp Biopharmaceutical

Series B

Mapp Biopharmaceutical: Innovating infectious disease prevention with ZMapp Ebola vaccine.

HQ
San Diego, CA, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Mapp Biopharmaceutical, founded in 2003 by Larry Zeitlin and Kevin Whaley, is headquartered in San Diego, California. The company’s core mission is to develop novel pharmaceuticals aimed at preventing and treating infectious diseases, with a particular focus on unmet global health and biodefense needs. Mapp Biopharmaceutical is best known for developing ZMapp, an experimental drug designed to combat the Ebola virus. The company also works on therapeutics for other infectious diseases, including Marburg virus.

Notable figures affiliated with Mapp Biopharmaceutical include co-founders Larry Zeitlin and Kevin Whaley, who serve as President and CEO, respectively. The company has garnered significant attention for its work on ZMapp, especially during the Ebola outbreaks. Collaborations with organizations such as BARDA have been instrumental in advancing their research and development efforts. Mapp Biopharmaceutical’s impact lies in its innovative approach to addressing critical infectious disease threats, contributing significantly to global health security.

Mapp Biopharmaceutical - Similar Companies

Emergent BioSolutions logo

Emergent BioSolutions

Biomarck Pharmaceuticals logo

Biomarck Pharmaceuticals

MBC Pharma logo

MBC Pharma

mbcpharma.com

Globavir Biosciences logo

Globavir Biosciences

MacroGenics logo

MacroGenics

macrogenics.com

Tempo Therapeutics logo

Tempo Therapeutics

tempothera.com

Gilead Sciences logo

Gilead Sciences

gilead.com

BioMap logo

BioMap

biomap.com

MapLight Therapeutics logo

MapLight Therapeutics

Flugen logo

Flugen

Moderna logo

Moderna

modernatx.com

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

Denovo Biopharma logo

Denovo Biopharma

Lumen Biomedical logo

Lumen Biomedical

lumenbio.com

Brii Biosciences logo

Brii Biosciences

briibio.com

Mapp Biopharmaceutical - Quick Facts

Who are Mapp Biopharmaceutical's competitors?

Companies similar to Mapp Biopharmaceutical include Emergent BioSolutions, Biomarck Pharmaceuticals, MBC Pharma and Globavir Biosciences.

When was Mapp Biopharmaceutical founded?

Mapp Biopharmaceutical was founded in 2003.

Where is Mapp Biopharmaceutical's headquarters located?

Mapp Biopharmaceutical's headquarters is located in San Diego, CA, US.

When was Mapp Biopharmaceutical's last funding round?

Mapp Biopharmaceutical's most recent funding round was for $16.5M (USD) in June 2019.

How much has Mapp Biopharmaceutical raised to-date?

As of Jun 23, 2019, Mapp Biopharmaceutical has raised a total of $16.5M (USD).

How many employees does Mapp Biopharmaceutical have?

Mapp Biopharmaceutical has 68 employees as of Feb 4, 2024.

Mapp Biopharmaceutical - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research